Dr. Marvalyn Elizabeth Decambre, FAAP, MD, MPH

Dr. Decambre practices at University Hospital in Newark, New Jersey, part of State of New Jersey.

Dr. Decambre's NPI, 1801967666, was assigned on November 13, 2006. Dr. Decambre graduated from University of Rochester School of Medicine and Dentistry in 1997. Dr. Decambre holds Missouri license 2013009218.

Dr. Decambre's primary practice is University Hospital, at 150 Bergen St, Newark, NJ 07103 in Essex County. The practice phone is (973) 972-4300.

Dr. Decambre's primary practice is University Hospital in Newark, New Jersey, part of State of New Jersey. Dr. Decambre is also affiliated with Memorial Medical Center. The medical group on file is AtlantiCare Physician Group. Dmand AI also links Dr. Decambre to 2 more medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Decambre practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Decambre's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Decambre is board certified in urology by the American Board of Urology. Dmand AI has Dr. Decambre's licenses on file in 12 states: Missouri, U.S. Virgin Islands, Florida, New Mexico, New York, Arizona, California, Delaware, New Jersey, Washington, Pennsylvania and Kansas.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney cysts, kidney removal surgery, kidney stone disease, pelvic prolapse, urinary endoscopy and urine flow blockage among the conditions Dr. Decambre treats.

CMS data shows 153 Medicare services from Dr. Decambre across 7 procedure codes in 2024, for 58 Medicare patients. Medicare paid $8,706 for them.

CMS counts 58 Medicare patients who saw Dr. Decambre in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have high blood pressure, and 74% have high cholesterol. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Decambre's median patient age at 47, with 42% women.

In 2024, Dr. Decambre wrote 201 Medicare Part D claims for 35 patients. 89% of them were for generic drugs. CMS names the drug for 156 of them, across 6 drugs with 11 or more claims each, at $36,137 in total drug cost. In 2023, CMS named 130 claims across 5 drugs.

Dr. Decambre accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Decambre as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Decambre, published from 2010 to 2013. 2013 was the busiest year, with 3. The most frequent topics are Laparoscopy and Vesico-Ureteral Reflux. Dr. Decambre has published most often in J Urol. Dr. Decambre's most frequent co-authors are Nicholas Matthew Holmes, MD, George J. Chiang, MD and Madhu Alagiri, MD.

CMS Open Payments shows 13 general payments to Dr. Decambre from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Progenics Pharmaceuticals, Inc. paid the most, $372.

Dmand AI lists 1 award for Dr. Decambre.

Dr. Decambre graduated from University of Rochester School of Medicine and Dentistry in 1997. Dr. Decambre is a member of AAP.

Dr. Decambre is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 13. Check the plan with the practice before a visit.